Sensitization to the Lysosomal Cell Death Pathway by Oncogene-Induced Down-regulation of Lysosome-Associated Membrane Proteins 1 and 2
Open Access
- 12 August 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (16), 6623-6633
- https://doi.org/10.1158/0008-5472.can-08-0463
Abstract
Expression and activity of lysosomal cysteine cathepsins correlate with the metastatic capacity and aggressiveness of tumors. Here, we show that transformation of murine embryonic fibroblasts with v-H-ras or c-srcY527F changes the distribution, density, and ultrastructure of the lysosomes, decreases the levels of lysosome-associated membrane proteins (LAMP-1 and LAMP-2) in an extracellular signal-regulated kinase (ERK)- and cathepsin-dependent manner, and sensitizes the cells to lysosomal cell death pathways induced by various anticancer drugs (i.e., cisplatin, etoposide, doxorubicin, and siramesine). Importantly, K-ras and erbb2 elicit a similar ERK-mediated activation of cysteine cathepsins, cathepsin-dependent down-regulation of LAMPs, and increased drug sensitivity in human colon and breast carcinoma cells, respectively. Notably, reconstitution of LAMP levels by ectopic expression or by cathepsin inhibitors protects transformed cells against the lysosomal cell death pathway. Furthermore, knockdown of either lamp1 or lamp2 is sufficient to sensitize the cells to siramesine-induced cell death and photo-oxidation–induced lysosomal destabilization. Thus, the transformation-associated ERK-mediated up-regulation of cysteine cathepsin expression and activity leads to a decrease in the levels of LAMPs, which in turn contributes to the enhanced sensitivity of transformed cells to drugs that trigger lysosomal membrane permeabilization. These data indicate that aggressive cancers with high cysteine cathepsin levels are especially sensitive to lysosomal cell death pathways and encourage the further development of lysosome-targeting compounds for cancer therapy. [Cancer Res 2008;68(16):6623–33]Other Versions
This publication has 43 references indexed in Scilit:
- Vincristine Induces Dramatic Lysosomal Changes and Sensitizes Cancer Cells to Lysosome-Destabilizing SiramesineCancer Research, 2007
- Apoptosome-Independent Activation of the Lysosomal Cell Death Pathway by Caspase-9Molecular and Cellular Biology, 2006
- Cathepsin B and tumor proteolysis: contribution of the tumor microenvironmentSeminars in Cancer Biology, 2005
- Multiple Roles for Cysteine Cathepsins in CancerCell Cycle, 2004
- Heat Shock Protein 70 Promotes Cell Survival by Inhibiting Lysosomal Membrane PermeabilizationThe Journal of Experimental Medicine, 2004
- Lysosomes in cell deathOncogene, 2004
- The Hallmarks of CancerCell, 2000
- Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposideOncogene, 1997
- Melanosomal and lysosomal alterations in murine melanocytes following transfection with the v-rasHa oncogeneInternational Journal of Cancer, 1996
- Oncogenic transformation alters cisplatin‐induced apoptosis in rat embryo fibroblastsInternational Journal of Cancer, 1995